PERK inhibition mitigates restenosis and thrombosis - a potential low-thrombogenic anti-restenotic paradigmBowen Wang(The Ohio State University Wexner Medical Center), K. Craig Kent(The Ohio State University)bioRxiv (Cold Spring Harbor Laboratory)March 18, 201910.1101/581397Cited by 4SaveCiteExport RISWatch citationsRelated PapersThe role of 6-phosphogluconate dehydrogenase in vascular smooth muscle cell phenotypic switching and angioplasty-induced intimal hyperplasia|JVS Vascular Science|2024|1